my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Tytonis -as integral part of a reputated, worldwide network of high-class, independent experts- offers services in all relevant areas of the pharmaceutical value chain. Focus areas are license transactions (deal values negotiated > 100 million Euros), valuations (corporate and products), portfoliost more
For more than 10 years have we been offering systematic searches for product and business development partners, also for specialists and executives to assist in growing your business. In excess of 3.000 contacts in our database are known in person, all can be accessed for advice. Potential partner more
Algeta ASA announced that it has appointed Donald Coppen as Business Development Director.Dr. Coppen will join Chief Business Officer Roger Harrison in driving Algeta's business development strategy aimed at advancing its Thorium payload technology for creating novel targeted cancer therapies, and e more
Deinove announced the appointment of Michael Krel to the newly created post of Executive Vice President, Business Development. For the three years prior to joining Deinove, Michael Krel served as Business Development Manager at Metabolic Explorer, a green chemistry company specializing in the develo more
Oxford Gene Technology (OGT) and Biotype Diagnostics GmbH announced the completion of a licence agreement granting Biotype access to OGT patents for the detection of DNA sequence variations. The licence, which will remain valid for the lifetime of the patents, provides Biotype with certain rights wi more
When working with DNA and oligo samples great care needs to be taken at every stage to ensure that degradation does not occur, and the highly potent samples are not contaminated. Use of state of the art concentration systems can significantly speed up concentration rates, saving researchers time, and also eliminate potential sources of damage to samples more
Looking at the increasing trend towards partnerships and alliances in the pharmaceutical industry, Frost & Sullivan a global growth consulting company had organized a premium conference, "Global PharmAlliance 2005 - Becoming the partner of choice" in Mumbai (India). The two day event focused on giving an insight into the world of partnerships and alliances through... more
Deal watch: Is deal-making becoming more difficult? Nature Reviews Drug Discovery 10, 404 (2011). doi:10.1038/nrd3464 Author: Nigel Borshell There has been much speculation on the impact of economic volatility and financial stress on deal-making over the past few years. To i more
2012 Deep Research Report on Global and China Hemodialysis Machine Industry was published by QYResearch Medical Equipment Research Center on Jan 2012. It was a professional and depth research report on Global and China Hemodialysis Machine Industry. Firstly the report describes the background knowle more
2012 Deep Research Report on China Influenza Vaccine Industry was a professional and depth research report on China Influenza Vaccine Industry. Firstly the report describes the background knowledge of Influenza Vaccine, including Concepts Classification Manufacturing process technical parameters and more
Hybrigenics S.A. (ALHYG) - Financial and Strategic SWOT Analysis Review Summary Hybrigenics S.A. (Hybrigenics) is a France-based bio-pharmaceutical company engaged in discovery and development of therapies for the treatment of cancer and commercialization of its technology and bioinformatics platf more
Watchlist
This is where you can add this topic to your personal favourites
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2012 CHEMIE.DE Information Service GmbH, All rights reserved
